The Johns Hopkins Hematology Fellowship Track is a proud member of the American Society of Hematology (ASH) Hematology-Focused Fellowship Training Program (HFFTP).
T32 Research Training Program in Hematology
The mission of the Johns Hopkins T32 Training Program in Hematology is to provide comprehensive academic training for post-doctoral fellows to develop basic, translational, and clinical research careers in Hematology. Established in 1982, our T32 Program is run by the Johns Hopkins Division of Hematology -- one of the only remaining free-standing hematology programs in the country -- in collaboration with complementary Departments including Molecular Biology & Genetics, Oncology, Pathology, and Pediatrics.
We welcome applications from postdoctoral fellows throughout the Johns Hopkins campus. As the program is funded by the National Heart, Blood, and Lung Institute (NHLBI), only US citizens, US noncitizen nationals, and individuals with permanent residence status are eligible to apply.
For more information, please contact:
Robert Brodsky, MD
Director, T32 Training Program in Hematology
Natalie Danish, CAP
Our Endowed Lectureships
The Division of Hematology is proud to host endowed lectureships to honor the lives of extraordinary hematology leaders and highlight exciting, cutting-edge research in non-malignant hematology from around the world.
William R. Bell Lectureship
Dr. William R. Bell (1935-2013) was a master clinician, an internationally acclaimed hematologist and a professor and researcher at The Johns Hopkins Hospital from 1974-2002.
“He loved working at JHH and was most passionate about his patients and working with colleagues committed to excellence in patient care. He has been credited with relief of suffering and many miracles from beloved patients through the years," states his wife of 47 years Dr. Barbara Bostock Bell."Normally we stay in our field of medicine, but Bill would see anyone who was sick and came to him. He'd give and give and give. He was a hardworking physician and over- caring for his patients is what he lived for," said Dr. Jerry Spivak, a JHH hematologist who was Chief of the Division of Hematology at Johns Hopkins from 1980-92. "If you were ever sick, you'd want Bill Bell for your doctor. He was tireless."
Isadore Brodsky Lectureship
Dr. Isadore Brodsky (1930-2007), was the Director of Hematology/Oncology at Hahnemann University Hospital. His interests and contributions to Hematology were vast. He worked under the mentorship of Dr. Wallace P. Rowe and Dr. Robert Huebner in the National Institute of Allergy and Infectious Diseases, where he and his colleagues were among the first to demonstrate the pathophysiologic link between retroviruses and cancer. Dr. Brodsky and his team at Hahnemann also established the first bone marrow transplant unit in the state of Pennsylvania. Later he collaborated with Johns Hopkins physicians on the use of high dose cyclophosphamide to treat aplastic anemia and other severe autoimmune conditions.
Dr. Brodsky had a passion for medicine and science. He was revered by his students, residents, and colleagues for his wisdom and teaching skills at bedside rounds and at lectures. He was also adored by his patients for his infinite determination, optimism and compassion.
Carlton Haywood Jr. Lectureship
Dr. Carlton Haywood Jr. (1977-2022) was an Assistant Professor in the Johns Hopkins Berman Institute of Bioethics and in the Division of Hematology at the Johns Hopkins School of Medicine, and a core faculty at the Welch Center for Prevention, Epidemiology, and Clinical Research within the Johns Hopkins Bloomberg School of Public Health. He received his PhD in the Health Policy and Ethics track in the department of Health Policy Management at the Johns Hopkins Bloomberg School of Public Health.
Dr. Haywood will be remembered for his groundbreaking health equity research, his tremendous personal and professional courage, and his work advocating to transform care for individuals with sickle cell disease. Dr. Haywood dedicated his dissertation to individuals living with sickle cell disease, a disease that he was also born with. “Our day will come,” he wrote.